Köşeci, T.; Seyyar, M.; Kıdı, M.M.; Biter, S.; Eser, K.; Kefeli, U.; Nayır, E.; Duman, B.B.; Mete, B.; Demirhindi, H.;
et al. Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin–Albumin–Lymphocyte–Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring. J. Clin. Med. 2025, 14, 1742.
https://doi.org/10.3390/jcm14051742
AMA Style
Köşeci T, Seyyar M, Kıdı MM, Biter S, Eser K, Kefeli U, Nayır E, Duman BB, Mete B, Demirhindi H,
et al. Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin–Albumin–Lymphocyte–Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring. Journal of Clinical Medicine. 2025; 14(5):1742.
https://doi.org/10.3390/jcm14051742
Chicago/Turabian Style
Köşeci, Tolga, Mustafa Seyyar, Mehmet Mutlu Kıdı, Sedat Biter, Kadir Eser, Umut Kefeli, Erdinç Nayır, Berna Bozkurt Duman, Burak Mete, Hakan Demirhindi,
and et al. 2025. "Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin–Albumin–Lymphocyte–Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring" Journal of Clinical Medicine 14, no. 5: 1742.
https://doi.org/10.3390/jcm14051742
APA Style
Köşeci, T., Seyyar, M., Kıdı, M. M., Biter, S., Eser, K., Kefeli, U., Nayır, E., Duman, B. B., Mete, B., Demirhindi, H., & Çil, T.
(2025). Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin–Albumin–Lymphocyte–Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring. Journal of Clinical Medicine, 14(5), 1742.
https://doi.org/10.3390/jcm14051742
